PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
United Laboratories International Holdings Ltd (39...
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

KYG8813K1085

Sector

Healthcare

IPO Date

Jun 15, 2007

Highlights

Market Cap

HK$21.59B

PE Ratio

6.99

Year Range

HK$5.99 - HK$12.58

Target Price

HK$12.11

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of HK$10,000 in United Laboratories International Holdings Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


250.00%300.00%350.00%400.00%AugustSeptemberOctoberNovemberDecember2025
382.02%
278.65%
3933.HK (United Laboratories International Holdings Ltd)
Benchmark (^GSPC)

Returns By Period

United Laboratories International Holdings Ltd had a return of -9.66% year-to-date (YTD) and 70.05% in the last 12 months. Over the past 10 years, United Laboratories International Holdings Ltd had an annualized return of 12.40%, outperforming the S&P 500 benchmark which had an annualized return of 11.26%.


3933.HK

YTD

-9.66%

1M

-6.34%

6M

38.08%

1Y

70.05%

5Y*

21.15%

10Y*

12.40%

^GSPC (Benchmark)

YTD

-0.93%

1M

-3.71%

6M

3.77%

1Y

21.81%

5Y*

12.17%

10Y*

11.26%

*Annualized

Monthly Returns

The table below presents the monthly returns of 3933.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-3.71%25.92%5.41%3.01%-2.49%-5.54%13.57%-0.78%15.53%4.55%0.19%17.39%94.14%
20235.92%-9.44%16.17%16.12%8.83%-5.22%-2.44%12.52%15.14%0.76%0.12%-12.38%49.11%
20221.38%-2.26%-4.63%-6.07%-3.10%24.00%-9.13%-7.97%-12.84%0.61%23.71%20.40%16.49%
2021-2.00%4.64%1.77%10.80%13.99%-12.14%-13.07%-3.67%-0.48%-4.83%-9.53%-2.24%-18.76%
2020-9.68%1.37%20.19%7.84%2.38%-2.90%8.97%26.18%-12.40%-16.79%-12.50%-5.34%-2.09%
20196.97%6.97%-2.52%-1.08%-3.49%-3.77%3.10%4.17%-8.44%9.47%6.43%18.33%38.92%
20187.87%18.25%0.37%4.92%6.92%-9.79%-8.44%-5.08%-2.25%-21.47%-3.12%-21.21%-34.03%
2017-8.15%3.09%1.40%-3.75%6.35%-0.77%-4.85%24.29%-4.43%16.67%-7.22%0.79%20.26%
2016-31.94%-3.08%10.25%3.85%-1.85%-4.09%-0.66%15.51%28.57%-4.66%-2.10%25.71%23.08%
2015-15.45%-7.31%2.25%44.35%13.93%-6.03%-16.58%-17.10%1.55%5.08%3.86%-0.23%-5.30%
201443.41%7.85%-3.74%7.99%-4.00%10.42%-2.64%15.50%-1.85%1.71%-11.93%-13.55%45.66%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 88, 3933.HK is among the top 12% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of 3933.HK is 8888
Overall Rank
The Sharpe Ratio Rank of 3933.HK is 9191
Sharpe Ratio Rank
The Sortino Ratio Rank of 3933.HK is 8888
Sortino Ratio Rank
The Omega Ratio Rank of 3933.HK is 8383
Omega Ratio Rank
The Calmar Ratio Rank of 3933.HK is 8787
Calmar Ratio Rank
The Martin Ratio Rank of 3933.HK is 8989
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for United Laboratories International Holdings Ltd (3933.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for 3933.HK, currently valued at 1.69, compared to the broader market-4.00-2.000.002.001.691.77
The chart of Sortino ratio for 3933.HK, currently valued at 2.48, compared to the broader market-4.00-2.000.002.004.002.482.37
The chart of Omega ratio for 3933.HK, currently valued at 1.28, compared to the broader market0.501.001.502.001.281.32
The chart of Calmar ratio for 3933.HK, currently valued at 1.41, compared to the broader market0.002.004.006.001.412.65
The chart of Martin ratio for 3933.HK, currently valued at 7.75, compared to the broader market0.0010.0020.007.7511.13
3933.HK
^GSPC

The current United Laboratories International Holdings Ltd Sharpe ratio is 1.69. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of United Laboratories International Holdings Ltd with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.501.001.502.002.503.00AugustSeptemberOctoberNovemberDecember2025
1.69
1.72
3933.HK (United Laboratories International Holdings Ltd)
Benchmark (^GSPC)

Dividends

Dividend History

United Laboratories International Holdings Ltd provided a 6.81% dividend yield over the last twelve months, with an annual payout of HK$0.76 per share. The company has been increasing its dividends for 6 consecutive years.


1.00%2.00%3.00%4.00%5.00%6.00%HK$0.00HK$0.20HK$0.40HK$0.60HK$0.802018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM2024202320222021202020192018
DividendHK$0.76HK$0.76HK$0.28HK$0.15HK$0.14HK$0.08HK$0.07HK$0.06

Dividend yield

6.81%6.15%4.05%3.06%3.32%1.39%1.20%1.47%

Monthly Dividends

The table displays the monthly dividend distributions for United Laboratories International Holdings Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025HK$0.00HK$0.00
2024HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.28HK$0.31HK$0.00HK$0.18HK$0.00HK$0.00HK$0.00HK$0.76
2023HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.15HK$0.00HK$0.13HK$0.00HK$0.00HK$0.00HK$0.28
2022HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.09HK$0.00HK$0.06HK$0.00HK$0.00HK$0.00HK$0.15
2021HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.10HK$0.00HK$0.05HK$0.00HK$0.00HK$0.00HK$0.14
2020HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.08HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.08
2019HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.07HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.07
2018HK$0.06HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.06

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%6.8%
United Laboratories International Holdings Ltd has a dividend yield of 6.81%, which means its dividend payment is significantly above the market average.
Payout Ratio
200.0%400.0%600.0%800.0%25.5%
United Laboratories International Holdings Ltd has a payout ratio of 25.48%, which is quite average when compared to the overall market. This suggests that United Laboratories International Holdings Ltd strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-9.66%
-4.23%
3933.HK (United Laboratories International Holdings Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the United Laboratories International Holdings Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the United Laboratories International Holdings Ltd was 83.09%, occurring on Jul 10, 2013. Recovery took 2822 trading sessions.

The current United Laboratories International Holdings Ltd drawdown is 9.66%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-83.09%Sep 14, 2010695Jul 10, 20132822Dec 24, 20243517
-75.08%Oct 16, 2007271Nov 21, 2008331Mar 24, 2010602
-26.39%Jul 10, 200729Aug 17, 200714Sep 6, 200743
-20.99%May 19, 20104May 25, 201015Jun 15, 201019
-14.01%Sep 14, 200713Oct 4, 20074Oct 10, 200717

Volatility

Volatility Chart

The current United Laboratories International Holdings Ltd volatility is 11.44%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%AugustSeptemberOctoberNovemberDecember2025
11.44%
4.62%
3933.HK (United Laboratories International Holdings Ltd)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of United Laboratories International Holdings Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of United Laboratories International Holdings Ltd compared to its peers in the Drug Manufacturers - Specialty & Generic industry.


PE Ratio
20.040.060.080.0100.07.0
The chart displays the price to earnings (P/E) ratio for 3933.HK in comparison to other companies of the Drug Manufacturers - Specialty & Generic industry. Currently, 3933.HK has a PE value of 7.0. This PE value is considered to be low compared to the rest of the industry.
PEG Ratio
-150.0-100.0-50.00.050.00.0
The chart displays the price to earnings to growth (PEG) ratio for 3933.HK in comparison to other companies of the Drug Manufacturers - Specialty & Generic industry. Currently, 3933.HK has a PEG value of 0.0. This PEG ratio falls in the average range for the industry.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for United Laboratories International Holdings Ltd.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab